Inflammatory Skin Diseases Treatment Market

Inflammatory Skin Diseases Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2026

Analysis of Inflammatory Skin Diseases Treatment Market Covering 30 + Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Introduction

Inflammatory skin diseases treatment is generally associated with wide co-morbidities such as diabetes and psoriasis arthritis. Inflammatory skin diseases can develop at any stage and in any age group. Inflammatory skin diseases are generally caused due to some genetic disposition and other environmental factors. Inflammatory skin diseases usually cause discomfort and anxiety.

The immune system plays an important role in the development of inflammatory skin diseases. Inflammatory skin diseases impact the patient’s mental health as it is a chronic condition which has a significant negative impact on the quality of life of those who suffer from the disease.

People with inflammatory skin diseases often suffer from physiological problems like low self-esteem, less coping responses, and also have feelings of social stigma, shame, and embarrassment regarding their appearance. As a result, inflammatory skin diseases have a debilitating effect on the quality of life of people suffering from it. Furthermore, this creates an immediate demand for inflammatory skin diseases treatment across the globe.

The increasing prevalence of atopic dermatitis and psoriasis are primarily responsible for driving the growth of the global inflammatory skin diseases treatment market. Atopic dermatitis is a type of chronic inflammatory skin condition which affects around 20% of children up to 3% of adults.

However, long term use of topical corticosteroids can sometimes cause a number of negative side effects such as damaging skin structure, increasing susceptibility to infections, and interfering with skin repair. Also, systematic treatment for inflammatory skin diseases cannot be provided to some patients with kidney or liver diseases, pregnant women and nursing mothers.

Thus, there is an unmet need existed for the new therapies that can are safe for long-term use and drugs that are in pipeline. These factors are responsible for hampering the growth of the global inflammatory skin diseases treatment market.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Key Players

The key players present in the global inflammatory skin diseases treatment market are Merck & Co., Inc., Amgen Inc., AbbVie Inc., Boehringer Ingelheim International GmbH, Pfizer Inc., Eli Lilly and Company, Novartis AG, and others.

The report covers exhaustive analysis on:

  • Inflammatory Skin Diseases Treatment Market Segments
  • Inflammatory Skin Diseases Treatment Market Dynamics
  • Historical Actual Inflammatory Skin Diseases Treatment Market Size, 2013 - 2017
  • Inflammatory Skin Diseases Treatment Market Size & Forecast 2017 to 2026
  • Inflammatory Skin Diseases Treatment Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Inflammatory Skin Diseases Treatment Market Drivers and Restraints

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Regional analysis includes:

  • North America
  • Latin America
  • Europe
  • Asia Pacific excluding China
  • China
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Segmentation

The global market for renal drugs is segmented on basis of inflammatory skin diseases treatment types, product types, distribution channel, and geography.

Based on inflammatory skin diseases treatment types, the global inflammatory skin diseases treatment market is segmented into:

  • Corticosteroids
  • Calcineurin Inhibitors
  • Retinoids
  • Others

Based on the product types, the global inflammatory skin diseases treatment market is segmented into:

  • Oral
  • Topical
  • Injectable

Based on the distribution channel, the global inflammatory skin diseases treatment market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • e-commerce

With the introduction of new treatments every year, inflammatory skin diseases treatment market is expected to evolve rapidly. The major players operating in the market are estimated to hold around 30-40% revenue share in the global inflammatory skin diseases treatment market. The inflammatory skin diseases treatment market leaders are focusing on business expansion in the emerging region. The increasing competition among the established key players in the inflammatory skin diseases treatment market is due to the development of novel and most efficacious drugs, which has directed these players to grab more market share in the global inflammatory skin diseases treatment market.

North America inflammatory skin diseases treatment market is expected to hold maximum market share in the global inflammatory skin diseases treatment market due to favorable regulations for inflammatory skin diseases treatment drugs, and funding for research and development. Furthermore, substantial economic development has greatly led to an increase in healthcare availability in the Asia Pacific region providing an opportunity for biopharmaceutical companies to penetrate in Asia Pacific region. Rising awareness towards inflammatory skin diseases treatment and collaborations to develop a new class of medicine for inflammatory skin diseases treatment are some of the factors fueling the growth of the market in Asia Pacific inflammatory skin diseases treatment market. However, Latin America inflammatory skin diseases treatment market and the Middle East and Africa inflammatory skin diseases treatment market are expected to witness a slow growth due to stringent regulatory approval in the region.  

Table of Content

1. Executive Summary

2. Industry Introduction, including Taxonomy and Market Definition

3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments

4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections

5. Pricing Analysis

6. Global Market Analysis and Forecast

    6.1. Treatment Types

    6.2. Product Type

    6.3. Distribution Channels

7. Global Market Analysis and Forecast, By Treatment Types

    7.1. Corticosteroids

    7.2. Calcineurin Inhibitors

    7.3. Retinoids

    7.4. Others

8. Global Market Analysis and Forecast, By Product Type

    8.1. Oral

    8.2. Topical

    8.3. Injectable

9. Global Market Analysis and Forecast, By Distribution Channels

    9.1. Hospital Pharmacies

    9.2. Retail Pharmacies

    9.3. e-commerce

10. Global Market Analysis and Forecast, By Region

    10.1. North America

    10.2. Latin America

    10.3. Western Europe

    10.4. Eastern Europe

    10.5. Asia Pacific

    10.6. East Asia

    10.7. MEA

11. North America Sales Analysis and Forecast, by Key Segments and Countries

12. Latin America Sales Analysis and Forecast, by Key Segments and Countries

13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries

14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries

15. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries

16. East Asia Sales Analysis and Forecast, by Key Segments and Countries

17. MEA Sales Analysis and Forecast, by Key Segments and Countries

18. Sales Forecast by Treatment Types, Product Type, and Distribution Channels for 30 Countries

19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard

20. Company Profile

    20.1. Merck & Co., Inc.

    20.2. Amgen Inc.

    20.3. AbbVie Inc.

    20.4. Boehringer Ingelheim International GmbH

    20.5. Pfizer Inc.

    20.6. Eli Lilly and Company

    20.7. Novartis AG

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 1: Global Market US$ Mn Forecast by Region

Table 2: Global Market US$ Mn Forecast by Treatment Types

Table 3: Global Market US$ Mn Forecast by Product Type

Table 4: Global Market US$ Mn Forecast by Distribution Channels

Table 5: North America Market US$ Mn Forecast by Country

Table 6: North America Market US$ Mn Forecast by Treatment Types

Table 7: North America Market US$ Mn Forecast by Product Type

Table 8: North America Market US$ Mn Forecast by Distribution Channels

Table 9: Latin America Market US$ Mn Forecast by Country

Table 10: Latin America Market US$ Mn Forecast by Treatment Types

Table 11: Latin America Market US$ Mn Forecast by Product Type

Table 12: Latin America Market US$ Mn Forecast by Distribution Channels

Table 13: Western Europe Market US$ Mn Forecast by Country

Table 14: Western Europe Market US$ Mn Forecast by Treatment Types

Table 15: Western Europe Market US$ Mn Forecast by Product Type

Table 16: Western Europe Market US$ Mn Forecast by Distribution Channels

Table 17: Eastern Europe Market US$ Mn Forecast by Country

Table 18: Eastern Europe Market US$ Mn Forecast by Treatment Types

Table 19: Eastern Europe Market US$ Mn Forecast by Product Type

Table 20: Eastern Europe Market US$ Mn Forecast by Distribution Channels

Table 21: Asia Pacific Market US$ Mn Forecast by Country

Table 22: Asia Pacific Market US$ Mn Forecast by Treatment Types

Table 23: Asia Pacific Market US$ Mn Forecast by Product Type

Table 24: Asia Pacific Market US$ Mn Forecast by Distribution Channels

Table 25: East Asia Market US$ Mn Forecast by Country

Table 26: East Asia Market US$ Mn Forecast by Treatment Types

Table 27: East Asia Market US$ Mn Forecast by Product Type

Table 28: East Asia Market US$ Mn Forecast by Distribution Channels

Table 29: MEA Market US$ Mn Forecast by Country

Table 30: MEA Market US$ Mn Forecast by Treatment Types

Table 31: MEA Market US$ Mn Forecast by Product Type

Table 32: MEA Market US$ Mn Forecast by Distribution Channels

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types

Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type

Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region

Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types

Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type

Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types

Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type

Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types

Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type

Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types

Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type

Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

Figure 21: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types

Figure 22: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type

Figure 23: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

Figure 24: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

Figure 25: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types

Figure 26: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type

Figure 27: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

Figure 28: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types

Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type

Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels

Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What are the factors driving the growth of inflammatory skin disease market?

The increasing prevalence of atopic dermatitis and psoriasis is primarily responsible for driving the growth of the global inflammatory skin disease treatment market.

Which region will spearhead the growth in the inflammatory skin disease market?

North America accounts for a leading share of the global inflammatory skin disease market.

Inflammatory Skin Diseases Treatment Market

Schedule a Call